An intranasal vaccine comprising SARS-CoV-2 spike receptor-binding domain protein entrapped in mannose-conjugated chitosan nanoparticle provides protection in hamsters

Abstract We developed a novel intranasal SARS-CoV-2 subunit vaccine called NARUVAX-C19/Nano based on the spike protein receptor-binding domain (RBD) entrapped in mannose-conjugated chitosan nanoparticles (NP). A toll-like receptor 9 agonist, CpG55.2, was also added as an adjuvant to see if this woul...

Whakaahuatanga katoa

Ngā taipitopito rārangi puna kōrero

Ngā kaituhi matua:	Kairat Tabynov, Maxim Solomadin, Nurkeldi Turebekov, Meruert Babayeva, Gleb Fomin, Ganesh Yadagiri, Sankar Renu, Toktassyn Yerubayev, Nikolai Petrovsky, Gourapura J. Renukaradhya, Kaissar Tabynov
Hōputu:	Artigo
Reo:	Inglês
I whakaputaina:	Nature Portfolio 2023-07-01
Rangatū:	Scientific Reports
Urunga tuihono:	https://doi.org/10.1038/s41598-023-39402-0
Ngā Tūtohu:	Tāpirihia he Tūtohu Kāore He Tūtohu, Me noho koe te mea tuatahi ki te tūtohu i tēnei pūkete!